© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
July 27, 2021
Evkeeza has been approved as an adjunct to other low-density lipoprotein cholesterol-lowering therapies to treat patients 12 years and older with homozygous familial hypercholesterolemia.
May 21, 2021
The FDA has approved Verquvo (vericiguat; Merck) tablets for adults with chronic heart failure.
April 27, 2021
The FDA has approved Gemtesa (vibegron; Urovant Sciences) tablets to treat overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency.
April 09, 2021
RET fusions and mutations drive many types of cancer.